Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial.

ABSTRACT: Circulating desmosine is not reduced by treatment with azithromycin in COPD but elevated desmosine may identify a patient group with a greater treatment response http://ow.ly/vN6N30mhBA1.

SUBMITTER: Chalmers JD 

PROVIDER: S-EPMC6230815 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature